Диагностика внекишечных проявлений воспалительных заболеваний кишечника: обзор

1. Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M et al. ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2024;18(1):1–37.

PMID: 37351850. https://doi.org/10.1093/ecco-jcc/jjad108

2. Kaz AM, Venu N. Diagnostic methods and biomarkers in inflammatory bowel disease. diagnostics. Diagnostics (Basel). 2025;15(11):1303.

PMID: 40506875. PMCID: PMC12154505. https://doi.org/10.3390/diagnostics15111303

3. Клинические рекомендации. Язвенный колит. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендаций Минздрава России. 2025. ID: 193_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/193_2 (дата обращения – 15.05.2026). (Clinical guidelines. Ulcerative colitis. Association of Coloproctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2025. ID: 193_2. URL: https://cr.minzdrav.gov.ru/preview-cr/193_2 (date of access – 15.05.2026) (In Russ.)).

4. Клинические рекомендации. Болезнь Крона. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендаций Минздрава России. 2025. ID: 176_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/176_2 (дата обращения – 15.05.2026). (Clinical guidelines. Crohn’s Disease. Association of Coloproctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2025. ID: 176_2. URL: https://cr.minzdrav.gov.ru/preview-cr/176_2 (date of access – 15.05.2026) (In Russ.)).

5. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106(1):110–19.

PMID: 20808297. https://doi.org/10.1038/ajg.2010.343

6. Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10(4):429–36.

PMID: 26721936. PMCID: PMC4946768. https://doi.org/10.1093/ecco-jcc/jjv232

7. Faggiani I, Fanizza J, D’Amico F, Allocca M, Zilli A, Parigi TL et al. Extraintestinal manifestations in inflammatory bowel disease: From pathophysiology to treatment. Biomedicines. 2024;12(8):1839.

PMID: 39200303. PMCID: PMC11351332. https://doi.org/10.3390/biomedicines12081839

8. Ossum AM, Palm O, Cvancarova M, Solberg IC, Vatn M, Moum B, Hoivik ML; IBSEN study group. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study. Scand J Gastroenterol. 2018;53(10–11):1250–56.

PMID: 30353756. https://doi.org/10.1080/00365521.2018.1518482

9. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history. Gut. 1998;42(3):387–91.

PMID: 9577346. PMCID: PMC1727027. https://doi.org/10.1136/gut.42.3.387

10. Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4(3):123–31.

PMID: 21710141. PMCID: PMC3261248. https://doi.org/10.1007/s12178-011-9085-8

11. Conigliaro P, Chimenti MS, Ascolani M, Triggianese P, Novelli L, Onali S et al. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Autoimmun Rev. 2016;15(2):184–90.

PMID: 26554932. https://doi.org/10.1016/j.autrev.2015.11.002

12. Tavassoli S, Shahabinasab I, Norouzi A, Amiriani T, Abdolahi N, Livani S et al. From bowel inflammation to the bone and joints: Musculoskeletal examination in inflammatory bowel disease (IBD). BMC Musculoskelet Disord. 2021;22(1):1019.

PMID: 34863148. PMCID: PMC8645134. https://doi.org/10.1186/s12891-021-04903-4

13. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.

PMID: 19297344. https://doi.org/10.1136/ard.2009.108233. Erratum in: Ann Rheum Dis. 2019;78(6):e59. PMID: 19297344.

https://doi.org/10.1136/ard.2009.108233corr1

14. D’Inca R, Sturniolo G. Biomarkers in IBD: What to utilize for the diagnosis? Diagnostics (Basel). 2023;13(18):2931.

PMID: 37761298. PMCID: PMC10527829. https://doi.org/10.3390/diagnostics13182931

15. Sen R, Goyal A, Hurley JA. Seronegative spondyloarthropathy. (Updated 2023 Jul 17). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459356/

16. Edara M, Bhatt V, Zanwar A, Koneru K, Patel AM, Jawade P. A study of clinical, radiological features and HLA-B27 serology of axial spondyloarthropathy with comparison of radiographic and non-radiographic disease. J Family Med Prim Care. 2022;11(8):4417–23.

PMID: 36352982. PMCID: PMC9638547. https://doi.org/10.4103/jfmpc.jfmpc_62_22

17. Seidman AJ, Limaiem F. Synovial fluid analysis. (Updated 2023 May 1). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537114.

18. Reddy Mundla GK, Rallapalli R, Galla SS, Ravindran B. A prospective study for diagnosing joint diseases by synovial fluid analysis and percutaneous needle biopsy of synovium. Int J Res Orthop. 2017;3(4):661–69.

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20172544

19. Nooh N, Turkawi R, Maybury M, Cardy C, Sahbudin I. Applications of musculoskeletal ultrasound in inflammatory arthritis. Clin Med (Lond). 2025;25(5):100508.

PMID: 40914461. PMCID: PMC12546444. https://doi.org/10.1016/j.clinme.2025.100508

20. Akhondi H, Blum MA, Gupta N. Polyarticular arthritis. (Updated 2025 Aug 9). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537170/

21. Lacout A, Rousselin B, Pelage J. CT and MRI of spine and sacroiliac involvement in spondyloarthropathy. AJR Am J Roentgenol. 2008;191(4):1016–23.

PMID: 18806136. https://doi.org/10.2214/ajr.07.3446

22. Vladimirova N, Moller J, Attauabi M, Madsen G, Seidelin J, Terslev L et al. Spine and sacroiliac joint involvement in newly diagnosed patients with inflammatory bowel disease: Clinical and MRI findings from a population-based cohort. Am J Gastroenterol. 2025;120(1):225–40.

PMID: 39162769. https://doi.org/10.14309/ajg.0000000000003039

23. Ungureanu L, Cosgarea R, Alexandru Badea M, Florentina Vasilovici A, Cosgarea I, Corina Șenila S. Cutaneous manifestations in inflammatory bowel disease (review). Exp Ther Med. 2020;20(1):31–37.

PMID: 32508989. PMCID: PMC7271697. https://doi.org/10.3892/etm.2019.8321

24. He R, Zhao S, Cui M, Chen Y, Ma J, Li J, Wang X. Cutaneous manifestations of inflammatory bowel disease: Basic characteristics, therapy, and potential pathophysiological associations. Front Immunol. 2023;14:1234535.

PMID: 37954590. PMCID: PMC10637386. https://doi.org/10.3389/fimmu.2023.1234535

25. Sahoo RL, Sethi SK, Dalabehera S, Mishra A, Patra R. Dermatological manifestations in inflammatory bowel disease. J Dermatol Case Rep. 2025;18(2):144–51.

https://doi.org/10.61705/jdcr.18.2.2025.144.151

26. Тарасова Л.В., Краснова Н.В., Гималиева Г.Г., Кольцова И.В., Цыганова Ю.В. Гангренозная пиодермия, язвенная форма как симптом болезни Крона: клинический случай. Клинический разбор в общей медицине. 2025;6(5):114–118. (Tarasova LV, Krasnova NV, Gimalieva GG, Koltsova IV, Tsyganova YuV. Gangrenous pyoderma, ulcerative form as a symptom of Crohn’s disease: A clinical case. Klinicheskiy razbor v obshchey meditsine = Clinical Review for General Practice. 2025;6(5):114–118 (In Russ.)).

EDN: JUOKJG. https://doi.org/10.47407/kr2025.6.5.00621

27. Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: A cohort study of 2402 patients. Medicine (Baltimore). 2008;87(5):281–93.

PMID: 18794711. https://doi.org/10.1097/MD.0b013e318187cc9c

28. Perez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema nodosum: A practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021;22(3):367–78.

PMID: 33683567. PMCID: PMC7938036. https://doi.org/10.1007/s40257-021-00592-w

29. George C, Deroide F, Rustin M. Pyoderma gangrenosum – a guide to diagnosis and management. Clin Med (Lond). 2019;19(3):224–28.

PMID: 31092515. PMCID: PMC6542232. https://doi.org/10.7861/clinmedicine.19-3-224

30. Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol. 2017;23(32):5836–48.

PMID: 28932076. PMCID: PMC5583569. https://doi.org/10.3748/wjg.v23.i32.5836

31. Rodriguez Duran M, O’Keefe GAD. Ocular extraintestinal manifestations and treatments in patients with inflammatory bowel disease. Front Ophthalmol (Lausanne). 2024;3:1257068.

PMID: 38983096. PMCID: PMC11182217. https://doi.org/10.3389/fopht.2023.1257068

32. Arzbecker M, Kopplin LJ. Manifestations and management of inflammatory eye disease in patients with inflammatory bowel disease. Ocul Immunol Inflamm. 2024;32(10):2348–53.

PMID: 38848110. https://doi.org/10.1080/09273948.2024.2362881

33. Harthan JS, Opitz DL, Fromstein SR, Morettin CE. Diagnosis and treatment of anterior uveitis: Optometric management. Clin Optom (Auckl). 2016;8:23–35.

PMID: 30214346. PMCID: PMC6095364. https://doi.org/10.2147/OPTO.S72079

34. Pytrus W. Akutko K, Pytrus T, Turno-Krecicka A. A review of ophthalmic complications in inflammatory bowel diseases. J Clin Med. 2022;11(24):7457.

PMID: 36556071. PMCID: PMC9781961. https://doi.org/10.3390/jcm11247457

35. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23(1):29–34.

PMID: 8835896. https://doi.org/10.1097/00004836-199607000-00009

36. Cheung O, Regueiro MD. Inflammatory bowel disease emergencies. Gastroenterol Clin North Am. 2003;32(4):1269–88.

PMID: 14696307. https://doi.org/10.1016/s0889-8553(03)00095-5